Lianhe Ratings Global Limited (“Lianhe Global”) has affirmed ‘A-’ global scale Long-term Issuer Credit Rating of Taizhou Huaxin Pharmaceutical Investment Co., Ltd. (“THPI” or “the company”); Issuer Rating Outlook is Stable
Taizhou Huaxin Pharmaceutical Investment Co., Ltd. (Rating Report)